Factors Associated with Long-term Retention in Antiretroviral Therapy Among People Living with HIV: Evidence from a Tertiary Hospital in Jakarta, Indonesia.
Journal of preventive medicine and public health = Yebang Uihakhoe chi(2024)
摘要
Objectives:This study investigated factors associated with the retention of people living with HIV on antiretroviral therapy (ART) during the first 3 years of treatment.
Methods:A retrospective study using electronic health records was conducted at a tertiary hospital in Jakarta, Indonesia. Adult HIV-positive patients who started ART from 2010 until 2020 were included. A binary logistic regression model was used to identify factors associated with ART retention in the first 3 years.
Results:In total, 535 respondents were included in the analysis. The ART retention rates for the first, second, and third years were 83.7%., 79.1%, and 77.2%, respectively. The multivariate analysis revealed a negative association between CD4 count when starting ART and retention. Patients with CD4 counts >200 cells/mL were 0.65 times less likely to have good retention than those with CD4 counts ≤ 200 cells/mL. The year of starting ART was also significantly associated with retention. Patients who started ART in 2010-2013 or 2014-2016 were less likely to have good retention than those who started ART in 2017-2020, with adjusted odds ratios of 0.52 and 0.40, respectively. Patients who received efavirenz-based therapy were 1.69 times more likely to have good retention than those who received nevirapine (95% CI, 1.05-2.72).
Conclusions:Our study revealed a decline in ART retention in the third year. The CD4 count, year of enrollment, and an efavirenz-based regimen were significantly associated with retention. Patient engagement has long been a priority in HIV programs, with interventions being implemented to address this issue.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要